Clinical Trials

A Phase 1/1b Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Gastrointestinal Malignancies


Study ID
Arcus BioSciences AB928CSP0003

NCT Number
NCT03720678 (Click on the NCT number for more information about the trial)

Research Study Number
2018-1042

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Arcus BioSciences


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now